Can K-ras gene mutation be utilized as prognostic biomarker for colorectal cancer patients receiving chemotherapy? A meta-analysis and systematic review.
<h4>Introduction</h4>K-ras gene mutations were common in colorectal patients, but their relationship with prognosis was unclear.<h4>Objective</h4>Verify prognostic differences between patient with and without mutant K-ras genes by reviewing the published evidence.<h4>Me...
Saved in:
| Main Authors: | Yuan-Yi Rui, Dan Zhang, Zong-Guang Zhou, Cun Wang, Lie Yang, Yong-Yang Yu, Hai-Ning Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0077901 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenic chemotherapy sensitizes RAS-mutated colorectal cancers to immune checkpoint inhibitors
by: Lucillia Bezu, et al.
Published: (2023-12-01) -
Association of various RAS codon mutations and prognostic outcomes of patients with colorectal liver metastases after hepatectomy
by: Xiao‐Gang Wu, et al.
Published: (2024-10-01) -
Noninvasive image texture analysis differentiates K-ras mutation from pan-wildtype NSCLC and is prognostic.
by: Glen J Weiss, et al.
Published: (2014-01-01) -
Intratumor Heterogeneity of K-Ras and p53 Mutations among Human Colorectal Adenomas Containing Early Cancer
by: Walter Giaretti, et al.
Published: (2000-01-01) -
Intratumor Heterogeneity of k-ras and p53 Mutations Among Human Colorectal Adenomas Containing Early Cancer
by: Walter Giaretti
Published: (2001-01-01)